Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Dual Exosite-binding Inhibitors of Insulin-degrading Enzyme Challenge Its Role as the Primary Mediator of Insulin Clearance in Vivo.

Durham TB, Toth JL, Klimkowski VJ, Cao JX, Siesky AM, Alexander-Chacko J, Wu GY, Dixon JT, McGee JE, Wang Y, Guo SY, Cavitt RN, Schindler J, Thibodeaux SJ, Calvert NA, Coghlan MJ, Sindelar DK, Christe M, Kiselyov VV, Michael MD, Sloop KW.

J Biol Chem. 2015 Aug 14;290(33):20044-59. doi: 10.1074/jbc.M115.638205. Epub 2015 Jun 17.

2.

Evaluating primary care delivery systems for an uninsured Hispanic immigrant population.

Tapp H, Smith HA, Dixon JT, Ludden T, Dulin M.

Fam Community Health. 2013 Jan-Mar;36(1):19-33. doi: 10.1097/FCH.0b013e31826d7562.

PMID:
23168343
3.

Platelet-mediated vascular dysfunction during acute lung injury.

Dixon JT, Gozal E, Roberts AM.

Arch Physiol Biochem. 2012 May;118(2):72-82. doi: 10.3109/13813455.2012.665463. Epub 2012 Mar 23. Review.

PMID:
22439828
4.

N,N-Bis(diphenyl-phosphino)-1,2-dimethyl-propyl-amine.

Cloete N, Visser HG, Roodt A, Dixon JT, Blann K.

Acta Crystallogr Sect E Struct Rep Online. 2008 Jan 23;64(Pt 2):o480. doi: 10.1107/S1600536808001839.

5.

Mechanistic investigations of the ethylene tetramerisation reaction.

Overett MJ, Blann K, Bollmann A, Dixon JT, Haasbroek D, Killian E, Maumela H, McGuinness DS, Morgan DH.

J Am Chem Soc. 2005 Aug 3;127(30):10723-30.

PMID:
16045361
6.

Ethylene trimerisation and tetramerisation catalysts with polar-substituted diphosphinoamine ligands.

Overett MJ, Blann K, Bollmann A, Dixon JT, Hess F, Killian E, Maumela H, Morgan DH, Neveling A, Otto S.

Chem Commun (Camb). 2005 Feb 7;(5):622-4. Epub 2004 Dec 10.

PMID:
15672156
7.

Highly selective chromium-based ethylene trimerisation catalysts with bulky diphosphinoamine ligands.

Blann K, Bollmann A, Dixon JT, Hess FM, Killian E, Maumela H, Morgan DH, Neveling A, Otto S, Overett MJ.

Chem Commun (Camb). 2005 Feb 7;(5):620-1. Epub 2004 Dec 10.

PMID:
15672155
8.

Ethylene tetramerization: a new route to produce 1-octene in exceptionally high selectivities.

Bollmann A, Blann K, Dixon JT, Hess FM, Killian E, Maumela H, McGuinness DS, Morgan DH, Neveling A, Otto S, Overett M, Slawin AM, Wasserscheid P, Kuhlmann S.

J Am Chem Soc. 2004 Nov 17;126(45):14712-3.

PMID:
15535683
9.

The discovery of a new structural class of cyclin-dependent kinase inhibitors, aminoimidazo[1,2-a]pyridines.

Hamdouchi C, Keyser H, Collins E, Jaramillo C, De Diego JE, Spencer CD, Dempsey JA, Anderson BD, Leggett T, Stamm NB, Schultz RM, Watkins SA, Cocke K, Lemke S, Burke TF, Beckmann RP, Dixon JT, Gurganus TM, Rankl NB, Houck KA, Zhang F, Vieth M, Espinosa J, Timm DE, Campbell RM, Patel BK, Brooks HB.

Mol Cancer Ther. 2004 Jan;3(1):1-9.

10.

First Cr(III)-SNS complexes and their use as highly efficient catalysts for the trimerization of ethylene to 1-hexene.

McGuinness DS, Wasserscheid P, Keim W, Morgan D, Dixon JT, Bollmann A, Maumela H, Hess F, Englert U.

J Am Chem Soc. 2003 May 7;125(18):5272-3.

PMID:
12720428
11.

Novel Cr-PNP complexes as catalysts for the trimerisation of ethylene.

McGuinness DS, Wasserscheid P, Keim W, Hu C, Englert U, Dixon JT, Grove C.

Chem Commun (Camb). 2003 Feb 7;(3):334-5.

PMID:
12613599
12.

Yolk sac-derived murine macrophage cell line has a counterpart during ES cell differentiation.

Inamdar M, Koch T, Rapoport R, Dixon JT, Probolus JA, Cram E, Bautch VL.

Dev Dyn. 1997 Dec;210(4):487-97.

13.

Virtual kinetics: using statistical experimental design for rapid analysis of enzyme inhibitor mechanisms.

Bronson DD, Daniels DM, Dixon JT, Redick CC, Haaland PD.

Biochem Pharmacol. 1995 Sep 7;50(6):823-31.

PMID:
7575644
14.

Villous hyperplasia of the gallbladder: an unusual sonographic appearance.

Dixon JT, Foster SC, Gauvin GP, Geoghegan L, Sullivan TJ.

J Ultrasound Med. 1993 Oct;12(10):619-20. No abstract available.

PMID:
8246341

Supplemental Content

Loading ...
Support Center